Irisin Has Evident Association With Insulin, HOMA-IR, and Glucagon In Obese Diabetic and Non-Diabetic Iraqi Women

Athir Kadhim Mohammed; Faris Abdul Kareem Khazaal; Sama Hazim Mohammed Salih

doi:10.61132/obat.v2i5.657

Authors

Athir Kadhim Mohammed Department of Medical Laboratory Techniques, College of Health and Medical Techniques AL-Turath University, Iraq
Faris Abdul Kareem Khazaal Madenat al-Elem University College, Iraq
Sama Hazim Mohammed Salih Institute of Medical Technology/Baghdad, Middle Technical University, Iraq

DOI:

https://doi.org/10.61132/obat.v2i5.657

Keywords:

Irisin, Glucagon, Type 2 Diabetes Mellitus, HOMA-β, HOMA-IR, Body Mass Index

Abstract

Objective: We aimed to explore that the association of irisin with various anthropometric and metabolic parameters in obese diabetics and non-diabetics Iraqi women. Methods: Eighty obese Iraqi women participated in this cross-sectional study grouped into 40 obese and 40 obese diabetics. The correlation coefficient between circulating irisin levels and metabolic parameters were performed. Results: Serum irisin levels in obese group showed highly significant positive correlations with body weight, WC, BMI, FPG, fasting insulin (FI), HOMA-IR and glucagon (r=0.8684, P> 0.0001 ; r = 0.8104, P> 0.0001; r = 0.8285, P <0.0001; r = 0.5876, P> 0.0001‎; r = 0.5283, P> 0.0005‎; r = 0.0005, P <0.0001; r = 0.5244, P> 0.0005) respectively, and significant negative correlation ‎with FPG, FI and HOMA-IR (r=-0.3246, P<0.041; r=-0.7903, P<0.0001; r=-0.6105, P<0.0001) respectively. Stepwise regression results showed that body weight, FPG, HOMA-IR and glucagon had significant independently related with irisin (β=‏2.3150, P<0.0001; β=-‎1.2200, P=‎0.0002; β=‎21.8760, P=0.02‎; β=‎-20.9800, P<‎0.005; β=‎0.0468, P=0.037) respectively. Conclusions: Irisin had a strong positive correlation with anthropometric parameters. Irisin independently associated with body weight, glucagon, HOMA-IR and FPG

Downloads

Download data is not yet available.

References

A. Roca-Rivada, C. Castelao, L. L. Senin, M. O. Landrove, J. Baltar, A. B. Crujeiras, L. M. Seoane, F. F. Casanueva, M. Pardo, A. Belén Crujeiras, L. M. Seoane, F. F. Casanueva, and M. Pardo, ‘FNDC5/irisin is not only a myokine but also an adipokine.’, PLoS One, vol. 8, no. 4, p. e60563, Jan. 2013.

P. Boström, J. Wu, M. P. M. Jedrychowski, A. Korde, L. Ye, J. C. Lo, K. a Rasbach, E. A. Boström, J. H. Choi, J. Z. Long, S. Kajimura, M. C. Zingaretti, B. F. Vind, H. Tu, S. Cinti, K. Højlund, S. P. Gygi, and B. M. Spiegelman, ‘A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.’, Nature, vol. 481, no. 7382, pp. 463–8, 2012.

M. G. Novelle, C. Contreras, A. Romero-Picó, M. López, and C. Diéguez, ‘Irisin, two years later’, Int. J. Endocrinol., vol. 2013, pp. 746281–746281, 2013.

S. Aydin, ‘Three new players in energy regulation: Preptin, adropin and irisin’, Peptides, vol. 56, pp. 94–110, Jun. 2014.

N. Chen, Q. Li, J. Liu, and S. Jia, ‘Irisin, an exercise-induced myokine as a metabolic regulator: An updated narrative review’, Diabetes. Metab. Res. Rev., vol. 32, no. 1, pp. 51–59, 2016.

M. Zhang, P. Chen, S. Chen, Q. Sun, Q. C. Zeng, J. Y. Chen, Y. X. Liu, X. H. Cao, M. Ren, and J. K. Wang, ‘The association of new inflammatory markers with type 2 diabetes mellitus and macrovascular complications: a preliminary study.’, Eur. Rev. Med. Pharmacol. Sci., vol. 18, no. 11, pp. 1567–72, 2014.

G. Sesti, F. Andreozzi, T. V. Fiorentino, G. C. Mannino, A. Sciacqua, M. a. Marini, and F. Perticone, ‘High circulating irisin levels are associated with insulin resistance and vascular atherosclerosis in a cohort of nondiabetic adult subjects’, Acta Diabetol., vol. 51, no. 5, pp. 1–9, Mar. 2014.

K. H. Park, L. Zaichenko, M. Brinkoetter, B. Thakkar, A. Sahin-Efe, K. E. Joung, M. a. Tsoukas, E. V. Geladari, J. Y. Huh, F. Dincer, C. R. Davis, J. a. Crowell, and C. S. Mantzoros, ‘Circulating irisin in relation to insulin resistance and the metabolic syndrome’, J. Clin. Endocrinol. Metab., vol. 98, no. 12, pp. 4899–4907, 2013.

Arhire LI, Mihalache L and Covasa M (2019) Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome. Front. Endocrinol. 10:524. doi: 10.3389/fendo.2019.00524

C. Gutierrez-Repiso, S. Garcia-Serrano, F. Rodriguez-Pacheco, E. Garcia-Escobar, J. J. Haro-Mora, J. Garcia-Arnes, S. Valdes, M. Gonzalo, F. Soriguer, F. J. Moreno-Ruiz, and A. Rodriguez-Cañete, ‘FNDC5 could be regulated by leptin in adipose tissue’, Eur. J. Clin. Invest., vol. 44, no. 10, pp. 918–925, 2014.

J. M. Moreno-Navarrete, F. Ortega, M. Serrano, E. Guerra, G. Pardo, F. Tinahones, W. Ricart, and J. M. Fernández-Real, ‘Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance.’, J. Clin. Endocrinol. Metab., vol. 98, no. 4, pp. E769-78, Feb. 2013.

A. Stengel, T. Hofmann, M. Goebel-Stengel, U. Elbelt, P. Kobelt, and B. F. Klapp, ‘Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-Correlation with body mass index’, Peptides, vol. 39, no. 1, pp. 125–30, Jan. 2013.

B. Ahrén, ‘β- and α-Cell Dysfunction in Subjects Developing Impaired Glucose Tolerance’, Diabetes, vol. 58, no. 3, pp. 726–731, 2009.

J. Gromada, I. Franklin, and C. B. Wollheim, ‘Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains.’, Endocr. Rev., vol. 28, no. 1, pp. 84–116, Feb. 2007.

S. Lok, J. Kuijper, L. Jelinek, and J. Kramer, ‘The human glucagon receptor encoding gene: structure, cDNA sequence and chromosomal localization’, Gene, vol. 140, no. 2, pp. 203–209, 1994.

P. Puigserver, ‘Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha.’, Int. J. Obes. (Lond)., vol. 29 Suppl 1, pp. S5–S9, 2005.

K. M. Habegger, K. Stemmer, C. Cheng, T. D. Muller, K. M. Heppner, N. Ottaway, J. Holland, J. L. Hembree, D. Smiley, V. Gelfanov, R. Krishna, A. M. Arafat, A. Konkar, S. Belli, M. Kapps, S. C. Woods, S. M. Hofmann, D. D’Alessio, P. T. Pfluger, D. Perez-Tilve, R. J. Seeley, M. Konishi, N. Itoh, A. Kharitonenkov, J. Spranger, R. D. DiMarchi, and M. H. Tsch??p, ‘Fibroblast growth factor 21 mediates specific glucagon actions’, Diabetes, vol. 62, no. 5, pp. 1453–1463, 2013.

American Diabetes Association, ‘Standards of Medical Care in Diabetes-2015’, Diabetes Care, vol. 38, pp. 1–94, 2015.

J. S. Flier and E. Maratos-Flier, ‘Obesity’, in Harrisons’s principles of Internal Medicine‎, 16th editi., K. DL, Ed. USA, McGraw-Hill Companies‎, 2005, pp. 422–430.

D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, ‘Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man’, Diabetologia, vol. 28, no. 7, pp. 412–419, Jul. 1985.

A. B. Crujeiras, M. Pardo, R. R. Arturo, N. C. Santiago, M. Zulet, J. A. Martínez, and F. F. Casanueva, ‘Longitudinal variation of circulating irisin after an energy restriction-induced weight loss and following weight regain in obese men and women’, Am. J. Hum. Biol., vol. 26, no. 2, pp. 198–207, Jan. 2014.

A. E. Huerta, P. L. Prieto-Hontoria, M. Fernández-Galilea, N. Sáinz, M. Cuervo, J. A. Martínez, and M. J. Moreno-Aliaga, ‘Circulating irisin and glucose metabolism in overweight/obese women: effects of α-lipoic acid and eicosapentaenoic acid.’, J. Physiol. Biochem., vol. 71, no. 3, pp. 547–58, Sep. 2015.

Li, Y., Xu, Z. Association between irisin and metabolic parameters in nondiabetic, nonobese adults: a meta-analysis. Diabetol Metab Syndr 14, 152 (2022). https://doi.org/10.1186/s13098-022-00922-w

J. a. Timmons, K. Baar, P. K. Davidsen, and P. J. Atherton, ‘Is irisin a human exercise gene?’, Nature, vol. 488, no. 7413, pp. E9–E10, 2012.

M. Pardo, A. B. Crujeiras, M. Amil, Z. Aguera, S. Jiménez-Murcia, R. Baños, C. Botella, R. de la Torre, X. Estivill, A. B. Fagundo, J. M. Fernández-Real, J. C. Fernández-García, G. Fruhbeck, J. Gómez-Ambrosi, R. Rodríguez, F. J. Tinahones, F. Fernández-Aranda, and F. F. Casanueva, ‘Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index.’, Int. J. Endocrinol., vol. 2014, p. 857270, Jan. 2014.

Kim S-H, Kim SE, Kim S, Ahn MB, Cho WK, Cho KS and Jung MH (2024) The association of serum irisin with anthropometric, metabolic, and bone parameters in obese children and adolescents. Front. Endocrinol. 14:1326851. doi: 10.3389/fendo.2023.1326851

J. Y. Huh, G. Panagiotou, V. Mougios, M. Brinkoetter, M. T. Vamvini, B. E. Schneider, and C. S. Mantzoros, ‘FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.’, Metabolism., vol. 61, no. 12, pp. 1725–38, Dec. 2012.

A. Negre-Salvayre, R. Salvayre, N. Augé, R. Pamplona, and M. Portero-Otín, ‘Hyperglycemia and glycation in diabetic complications.’, Antioxid. Redox Signal., vol. 11, no. 12, pp. 3071–109, Dec. 2009.

L. Gamas, P. Matafome, and R. Seiça, ‘Irisin and myonectin regulation in the insulin resistant muscle: implications to adipose tissue: muscle crosstalk’, J. Diabetes Res., no. ID 359159, p. 8, 2015.

D. P. Kelly, ‘Irisin, Light My Fire’, Science (80-. )., vol. 336, no. 6077, pp. 42–43, 2012.

Ibrahim, I., & Salih, S. (2022). Serum Irisin In Individuals with Type 2 Diabetes Mellitus and Prediabetes in Duhok City. Journal of Life and Bio Sciences Research , 3(02), 59 - 64. https://doi.org/10.38094/jlbsr30277 [32] G. Mohammadzadeh and N. Zarghami, ‘Serum leptin level is reduced in non-obese subjects with type 2 diabetes.’, Int. J. Endocrinol. Metab., vol. 11, no. 1, pp. 3–10, Jan. 2013.

T. Ebert, H. Stepan, S. Schrey, S. Kralisch, J. Hindricks, L. Hopf, M. Platz, U. Lossner, B. Jessnitzer, S. Drewlo, and M. and Blüher, ‘Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery’, Cytokine, vol. 65, no. 2, pp. 153–158, Feb. 2014.

M. Yang, P. Chen, H. Jin, X. Xie, T. Gao, L. Yang, and X. Yu, ‘Circulating levels of irisin in middle-aged first-degree relatives of type 2 diabetes mellitus - correlation with pancreatic β-cell function.’, Diabetol. Metab. Syndr., vol. 6, no. 1, p. 133, Jan. 2014.

T. Ebert, D. Focke, D. Petroff, U. Wurst, J. Richter, A. Bachmann, U. Lössner, S. Kralisch, J. Kratzsch, J. Beige, and I. and Bast, ‘Serum levels of the myokine irisin in relation to metabolic and renal function’, Eur. J. Endocrinol., vol. 170, no. 4, pp. 501–506, Apr. 2014.

F. Sanchis-Gomar and C. Perez-Quilis, ‘The p38-PGC-1α-irisin-betatrophin axis: Exploring new pathways in insulin resistance.’, Adipocyte, vol. 3, no. 1, pp. 67–8, 2014.

Kadham, S. M., Mustafa, M. A., Abbass, N. K., & Karupusamy, S. (2024). IoT and artificial intelligence–based fuzzy-integral N-transform for sustainable groundwater management. Applied Geomatics, 16(1), 1-8.‏

Ali, S. H., Armeet, H. S., Mustafa, M. A., & Ahmed, M. T. (2022, November). Complete blood count for COVID-19 patients based on age and gender. In AIP Conference Proceedings (Vol. 2394, No. 1). AIP Publishing.‏

Shakir, O. M., Abdulla, K. K., Mustafa, A. A., & Mustafa, M. A. (2019). Investigation of the presence of parasites that contaminate some fruits and vegetables in the Samarra City in Iraq. Plant Arch, 19, 1184-1190.‏

Abdulqader, A. T., Al-Sammarie, A. M. Y., & Mustafa, M. A. (2022, May). A comparative environmental study of aqueous extracts of ginger and grapes to protect hepatocytes in Albino rabbits and a comparison of extracts in preserving Awassi lamb meat from oxidation. In IOP Conference Series: Earth and Environmental Science (Vol. 1029, No. 1, p. 012001). IOP Publishing.‏

Kadham, S. M., Mustafa, M. A., Abbass, N. K., & Karupusamy, S. (2023). Comparison between of fuzzy partial H-transform and fuzzy partial Laplace transform in x-ray images processing of acute interstitial pneumonia. International Journal of System Assurance Engineering and Management, 1-9.‏

Meri, M. A., Ibrahim, M. D., Al-Hakeem, A. H., & Mustafa, M. A. (2023). Procalcitonin and NLR Measurements in COVID-19 Patients. Latin American Journal of Pharmacy, 220-223.‏

Mustafa, M. A., Raja, S., Asadi, L. A. A., Jamadon, N. H., Rajeswari, N., & Kumar, A. P. (2023). A Decision‐Making Carbon Reinforced Material Selection Model for Composite Polymers in Pipeline Applications. Advances in Polymer Technology, 2023(1), 6344193.‏

Valluru, D., Mustafa, M. A., Jasim, H. Y., Srikanth, K., RajaRao, M. V. L. N., & Sreedhar, P. S. S. (2023, March). An Efficient Class Room Teaching Learning Method Using Augmented Reality. In 2023 9th International Conference on Advanced Computing and Communication Systems (ICACCS) (Vol. 1, pp. 300-303). IEEE.‏

Mustafa, M. A., Kadham, S. M., Abbass, N. K., Karupusamy, S., Jasim, H. Y., Alreda, B. A., ... & Ahmed, M. T. (2024). A novel fuzzy M-transform technique for sustainable ground water level prediction. Applied Geomatics, 16(1), 9-15.‏